Cytotoxic Therapies Market ForecastDatamonitor
August 5, 2010
27 Pages - SKU: DFMN2769343
More Oncology/Hematology reports by Datamonitor
Pipeline: Colorectal Cancer by Datamonitor
IntroductionTargeted therapies continue to dominate the colorectal cancer pipeline. With two new approvals in 2012, drug developers must now move away from anti-VEGF drugs toward ...
Pipeline: Renal Cell Cancer by Datamonitor
IntroductionSeven targeted therapies are available for the treatment of RCC but there is still considerable pipeline activity. Currently approved targeted therapies have been unable to ...
Market Forecasts: Non-Small Cell Lung Cancer by Datamonitor
Introduction This report assesses the current and future non-small cell lung cancer market across the US, Japan, France, Germany, Italy, Spain, and the UK ...
Forecast: Non-Small Cell Lung Cancer in China by DatamonitorSee all reports like this >>
IntroductionPharmaceutical companies have been attracted by the high incidence of NSCLC in China and the pipeline has grown substantially. The treatment of NSCLC will continue ...
We can help you find what you need. Call us or write us:
Need help in your search?
- Generics Drugs
- Manufacturing, Packaging & Detailing
- Therapeutic Area
- Lymphoma Treatment Drugs Markets in China
- Metastatic Adenocarcinoma of The Pancreas – Pipeline Review, H1 2013
- Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2013
- Metastatic Ovarian Cancer – Pipeline Review, H1 2013
- Recurrent Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H1 2013